CECOG Academy

www.cecog.org

 

CECOG Academy
Avatar

Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patients Who Benefit From It

By CECOG Academy FEATURING Gerald Prager
By CECOG Academy FEATURING Gerald Prager
223 views
December 7, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das
CECOG Immuno-Oncology Symposium
37:56

Combining Immune Checkpoint Inhibitors With Tyrosine Kinase Inhibito…

CECOG Academy

T. Füreder

192 views
13:03

Updates on Cabozantinib in RCC, HCC, and Thyroid Cancers

CECOG Academy

B. Mrinakova

157 views
07:41

Efficacy of FDA-Approved Lenvatinib in Solid Cancers

CECOG Academy

A. Perdyan

44 views
29:34

From Bench to Bedside - CLL: Steps to Chemo-Free Therapy

CECOG Academy

U. Jaeger

150 views
40:57

SARS-CoV-2 Pandemic: Vaccination Against Coronavirus in Patients wit…

CECOG Academy

U. Wiedermann-Schmidt

32 views
20:53

Advances in IO Maintenance Treatment of Ovarian Cancer

CECOG Academy

C. Grimm

380 views
27:45

Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patien…

CECOG Academy

G. Prager

223 views
09:47

Entrectinib in Advanced NSCLC and Other Solid Tumors: Updates and Ne…

CECOG Academy

A. Bandura

172 views
24:08

Advances in IO Neoadjuvant Treatment With Immune Checkpoint Inhibito…

CECOG Academy

C. Zielinski

38 views
26:59

Targeting KRAS Mutations in NSCLC

CECOG Academy

M. Filipits

85 views
28:43

Optimizing Immunotherapy for NSCLC in Daily Practice

CECOG Academy

T. Cufer

94 views
47:06

Positioning Immune Checkpoint Inhibitor Treatment for TNBC

CECOG Academy

R. Bartsch

116 views
27:01

Sequence of Treatment for Metastatic Prostate Cancer

CECOG Academy

G. Kramer

367 views